PARP Inhibitors: Revolutionising Cancer Treatment 

Cells try to repair damaged DNA via a natural repair system called PARP - but cancers also take advantage of this repair system to thrive. This is the principle underlying the development of potential new therapies, including a next-generation PARP inhibitor that is designed to selectively maximise DNA damage to cancer cells. Our aim? To open up the possibility for powerful combination therapies- all for the benefit of patients.
Learn more about our work in DNA damage response: Combatting cancer by exploiting the DNA Damage Response
www.astrazeneca.com/our-thera...
------------------------------------------------------------------------
Global site: www.astrazeneca.com/
Careers site: careers.astrazeneca.com/
Follow us:
Twitter: / astrazeneca
LinkedIn: / astrazeneca
Instagram: / astrazeneca
Facebook: / astrazeneca

Наука